NASDAQ: $ONC
SAN CARLOS, Calif.–(BUSINESS WIRE) Aug 25, 2026 — BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics…
Source: Read More